文章摘要

参考文献/References:

1 Graham BL, Steenbruggen I, Miller MR, et al. Standardization of spirometry 2019 update. an official american thoracic society and european respiratory society technical statement[J]. Am J Respir Crit Care Med, 2019, 200(8): e70-e88.
2 中华医学会呼吸病学分会肺功能专业组. 肺功能检查指南(第二部分)-肺量计检查[J]. 中华结核和呼吸杂志, 2014, 37(7): 481-486.
3 中国医药教育协会慢性气道疾病专业委员会, 中国哮喘联盟. 呼出气一氧化氮检测及其在气道疾病诊治中应用的中国专家共识[J]. 中华医学杂志, 2021, 101(38): 3092-3114.
4 朱蕾, 陈荣昌. 成人常规肺功能测定规范中国专家共识[J]. 临床肺科杂志, 2022, 27(11): 1621-1633.
5 Stanojevic S, Kaminsky DA, Miller MR, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests[J]. Eur Respir J, 2022, 60(1): 2101499.
6 Graham BL, Brusasco V, Burgos F, et al. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung[J]. Eur Respir J, 2017, 49(1): 1600016.
7 中华医学会呼吸病学分会肺功能专业组. 肺功能检查指南-肺容量检查[J]. 中华结核和呼吸杂志, 2015, 38(4): 255-260.
8 刘桂蕊, 王枢传, 李潭溪. 临床肺功能指南[M]. 天津: 天津科学技术出版社, 1988: 53-56.
9 中华医学会呼吸病学分会肺功能专业组. 肺功能检查指南——体积描记法肺容量和气道阻力检查[J]. 中华结核和呼吸杂志, 2015, 38(5): 342-347.
10 中国医师协会呼吸医师分会肺功能与临床呼吸生理工作委员会, 中华医学会呼吸病学分会肺功能学组, 中国老年医学会呼吸分会肺功能学组. 肺功能检查技术规范——脉冲振荡技术检查[J]. 中华结核和呼吸杂志, 2022, 45(10): 960-969.
11 Barjaktarevic IZ, Buhr RG, Wang X, et al. Clinical significance of bronchodilator responsiveness evaluated by forced vital capacity in COPD: SPIROMICS cohort analysis[J]. Int J Chron Obstruct Pulmon Dis, 2019, 14: 2927-2938.
12 Quanjer PH, Ruppel GL, Langhammer A, et al. Bronchodilator response in FVC is larger and more relevant than in FEV₁ in severe airflow obstruction[J]. Chest, 2017, 151(5): 1088-1098.
13 Chen C, Jian W, Gao Y, et al. Early COPD patients with lung hyperinflation associated with poorer lung function but better bronchodilator responsiveness[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11: 2519-2526.
14 Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests[J]. Eur Respir J, 2005, 26(5): 948-968.
15 Ward H, Cooper BG, Miller MR. Improved criterion for assessing lung function reversibility[J]. Chest, 2015, 148(4): 877-886.
16 Brand PL, Quanjer PH, Postma DS, et al. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease(CNSLD)Study Group[J]. Thorax, 1992, 47(6): 429-436.
17 Tan WC, Vollmer WM, Lamprecht B, et al. Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study[J]. Thorax, 2012, 67(8): 718-726.
18 Ioachimescu OC, Ramos JA, Hoffman M, et al. Assessing bronchodilator response by changes in per cent predicted forced expiratory volume in one second[J]. J Investig Med, 2021, 69(5): 1027-1034.
19 Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China(the China Pulmonary Health [CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717.
20 Huang K, Yang T, Xu J, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study[J]. Lancet, 2019, 394(10196): 407-418.
21 Allan L Coates, Jack Wanger, Donald W Cockcroft, et al. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests[J]. Eur Respir J, 2017, 49(5): 1601526.
22 中国医师协会呼吸医师分会肺功能与临床呼吸生理工作委员会, 中华医学会呼吸病学分会, 中国老年医学会呼吸分会肺功能学组. 乙酰甲胆碱(氯醋甲胆碱)支气管激发试验技术规范(2023年版)[J]. 中华结核和呼吸杂志, 2024, 47(2): 1-19.
23 中华医学会儿科学分会呼吸学组肺功能协作组,《中华实用儿科临床杂志》编辑委员会. 儿童肺功能系列指南(六):支气管激发试验[J]. 中华实用儿科临床杂志, 2017, 32(4): 263-269.
24 杨宏宽, 张佳颖, 王芳, 等. Astograph法支气管激发试验在诊断哮喘的作用研究[J]. 实用医学杂志, 2017, 33(22): 3807-3809.
25 Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations[J]. Eur Respir J, 2012, 40(6): 1324-1343.
26 Zhang J, Hu X, Shan G. Spirometry reference values for population aged 7-80 years in China[J]. Respirology, 2017, 22(8): 1630-1636.
27 Wu Y, Zhang Z, Gang B, et al. Predictive equations for lung function based on a large occupational population in North China[J]. J Occup Health, 2009, 51(6): 471-477.
28 Ip MS, Ko FW, Lau AC, et al. Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization[J]. Chest, 2006, 129(2): 384-392.
29 Jian W, Gao Y, Hao C, et al. Reference values for spirometry in Chinese aged 4-80 years[J]. J Thorac Dis, 2017, 9(11): 4538-4549.
30 Gao C, Zhang X, Wang D, et al. Reference values for lung function screening in 10- to 81-year-old, healthy, never-smoking residents of Southeast China[J]. Medicine(Baltimore), 2018, 97(34): e11904.
31 Stanojevic S, Graham BL, Cooper BG, et al. Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians[J]. Eur Respir J, 2017, 50(3): 1700010.
32 Hall GL, Filipow N, Ruppel G, et al. Official ERS technical standard: Global Lung Function Initiative reference values for static lung volumes in individuals of European ancestry[J]. Eur Respir J, 2021, 57(3): 2000289.
33 Culver BH, Graham BL, Coates AL, et al. Recommendations for a standardized pulmonary function report. an official american thoracic society technical statement[J]. Am J Respir Crit Care Med, 2017, 196(11): 1463-1472.
34 Stanojevic S, Wade A, Stocks J, et al. Reference ranges for spirometry across all ages: a new approach[J]. Am J Respir Crit Care Med, 2008, 177(3): 253-260.
35 Global Initiative for Asthma. Global strategy for asthma management and prevention[EB/OL].(2023)[2023-07-06]. https://ginasthma. org/wp-content/uploads/2023/07/GINA-2023-Full-report-23_07_06-WMS.pdf.
36 中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(2020年版)[J]. 中华结核和呼吸杂志, 2020, 43(12): 1023-1048.
37 Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease(2024 REPORT)[EB/OL].(2023)[2024-03-25]. https://goldcopd.org/2024-gold-report/.
38 中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版)[J]. 中华结核和呼吸杂志, 2021, 44(3): 170-205.
39 Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic pulmonary fibrosis(an update)and progressive pulmonary fibrosis in adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline[J]. Am J Respir Crit Care Med, 2022, 205(9): e18-e47.
40 中国研究型医院学会呼吸病学专业委员会. 特发性炎性肌病相关间质性肺疾病诊断和治疗中国专家共识[J]. 中华结核和呼吸杂志, 2022, 45(7): 635-650.
41 Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis[J]. N Engl J Med, 2014, 370(22): 20712082.
42 司法部司法鉴定管理局, 最高人民法院司法行政装备管理局. 《人体损伤致残程度分级》适用指南[M]. 北京: 法律出版社, 2016: 102-106.
43 中华医学会儿科学分会呼吸学组肺功能协作组, 《中华实用儿科临床杂志》编辑委员会. 儿童肺功能系列指南(三):脉冲振荡[J]. 实用儿科临床杂志, 2016, 31(11): 821-825.
44 Su ZQ, Guan WJ, Li SY, et al. Significances of spirometry and impulse oscillometry for detecting small airway disorders assessed with endobronchial optical coherence tomography in COPD[J]. Int J Chron Obstruct Pulmon Dis, 2018, 13: 3031-3044.
45 Shinke H, Yamamoto M, Hazeki N, et al. Visualized changes in respiratory resistance and reactance along a time axis in smokers: a cross-sectional study[J]. Respir Investig, 2013, 51(3): 166-174.
46 Milne S, Hammans C, Watson S, et al. Bronchodilator responses in respiratory impedance, hyperinflation and gas trapping in COPD[J]. COPD, 2018, 15(4): 341-349.
47 King GG, Bates J, Berger KI, et al. Technical standards for respiratory oscillometry[J]. Eur Respir J, 2020, 55(2): 1900753.
48 Broeders ME, Molema J, Hop WC, et al. Bronchial challenge, assessed with forced expiratory manoeuvres and airway impedance[J]. Respir Med, 2005, 99(8): 1046-1052.
49 Antonicelli L, Tontini C, Marchionni A, et al. Forced oscillation technique as method to document and monitor the efficacy of mepolizumab in treating severe eosinophilic asthma[J]. Allergy, 2020, 75(2): 433-436.
50 da Costa GM, Faria AC, Di Mango AM, et al. Respiratory impedance and response to salbutamol in healthy individuals and patients with COPD[J]. Respiration, 2014, 88(2): 101-111.
51 Jetmalani K, Timmins S, Brown NJ, et al. Expiratory flow limitation relates to symptoms during COPD exacerbations requiring hospital admission[J]. Int J Chron Obstruct Pulmon Dis, 2015, 10: 939-945.
52 British Thoracic Society, Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery[J]. Thorax, 2001, 56(2): 89-108.
53 Colice GL, Shafazand S, Griffin JP, et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines(2nd edition)[J]. Chest, 2007, 132(3 Suppl): 161s-177s.
54 Ferguson MK, Little L, Rizzo L, et al. Diffusing capacity predicts morbidity and mortality after pulmonary resection[J]. J Thorac Cardiovasc Surg, 1988, 96(6): 894-900.
55 Licker MJ, Widikker I, Robert J, et al. Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends[J]. Ann Thorac Surg, 2006, 81(5): 1830-1837.
56 Ferguson MK, Dignam JJ, Siddique J, et al. Diffusing capacity predicts long-term survival after lung resection for cancer[J]. Eur J Cardiothorac Surg, 2012, 41(5): e81-e86.
57 Brunelli A, Kim AW, Berger KI, et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines[J]. Chest, 2013, 143(5 Suppl): e166S-e190S.
58 Sawabata N, Nagayasu T, Kadota Y, et al. Risk assessment of lung resection for lung cancer according to pulmonary function: republication of systematic review and proposals by guideline committee of the Japanese association for chest surgery 2014[J]. Gen Thorac Cardiovasc Surg, 2015, 63(1): 14-21.
59 姜格宁, 张雷, 朱余明, 等. 肺切除手术患者术前肺功能评估肺科共识[J]. 中国胸心血管外科临床杂志, 2020, 27(1): 1-9.
60 Lim E, Baldwin D, Beckles M, et al. Guidelines on the radical management of patients with lung cancer[J]. Thorax, 2010, 65 Suppl 3: iii1-iii27.
61 Dan Xiao, Zhengming Chen, Sinan Wu, er al. Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study[J]. Lancet Respir Med, 2020, 8(11): 1081-1093.
62 Mannino DM, McBurnie MA, Tan W, et al. Restricted spirometry in the Burden of Lung Disease Study[J]. Int J Tuberc Lung Dis, 2012, 16(10): 1405-1411.
63 Wan ES, Castaldi PJ, Cho MH, et al. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry(PRISm)in COPDGene[J]. Respir Res, 2014, 15(1): 89.
64 赵宁宁, 周玉民. 保留比值受损肺功能人群研究进展[J]. 中华结核和呼吸杂志, 2022, 45(10): 1046-1050.
65 He D, Sun Y, Gao M, et al. Different risks of mortality and longitudinal transition trajectories in new potential subtypes of the preserved ratio impaired spirometry: evidence from the english longitudinal study of aging[J]. Front Med(Lausanne), 2021, 8: 755855.
66 Miura S, Iwamoto H, Omori K, et al. Preserved ratio impaired spirometry with or without restrictive spirometric abnormality[J]. Sci Rep, 2023, 13(1): 2988.
67 Wan ES, Hokanson JE, Regan EA, et al. Significant spirometric transitions and preserved ratio impaired spirometry among ever smokers[J]. Chest, 2022, 161(3): 651-661.
68 Wijnant SRA, De Roos E, Kavousi M, et al. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study[J]. Eur Respir J, 2020, 55(1): 1901217.
69 Miller MR, Pedersen OF. New concepts for expressing forced expiratory volume in 1 s arising from survival analysis[J]. Eur Respir J, 2010, 35(4): 873-882.
70 Eralda Hegendörfer, Bert Vaes, Elena Andreeva, et al. Predictive value of different expressions of forced expiratory volume in 1 second(FEV₁)for adverse outcomes in a cohort of adults aged 80 and older[J]. J Am Med Dir Assoc, 2017, 18(2): 123-130.
71 Elizabeth C Oelsner, Pallavi P Balte, Surya P Bhatt, et al. Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI Pooled Cohorts Study[J]. Lancet Respir Med, 2020, 8(1): 34-44.
72 Carrie A Redlich, Susan M Tarlo, John L Hankinson, et al. Official American Thoracic Society technical standards: spirometry in the occupational setting[J]. Am J Respir Crit Care Med, 2014, 189(8): 983-993.
73 Johannes Luoto, Mats Pihlsgård, Per Wollmer, et al. Relative and absolute lung function change in a general population aged 60-102 years[J]. Eur Respir J, 2019, 53(3): 1701812.

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

文章信息/Info

参考文献/References:

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics